{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:44:00Z","timestamp":1778939040654,"version":"3.51.4"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T00:00:00Z","timestamp":1510272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0187755","type":"journal-article","created":{"date-parts":[[2017,11,10]],"date-time":"2017-11-10T13:25:54Z","timestamp":1510320354000},"page":"e0187755","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods"],"prefix":"10.1371","volume":"12","author":[{"given":"Elisabetta","family":"Loggi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Di Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranka","family":"Vukotic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Grandini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzia","family":"Margotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliano","family":"Furlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carla","family":"Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4794-9809","authenticated-orcid":true,"given":"Pietro","family":"Andreone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,11,10]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.2014.7085","article-title":"Treatment of hepatitis C: a systematic review","volume":"312","author":"A Kohli","year":"2014","journal-title":"Jama"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL Recommendations on Treatment of Hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22070","article-title":"Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop","volume":"47","author":"RT Chung","year":"2008","journal-title":"Hepatology"},{"issue":"Suppl 5","key":"ref4","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/j.dld.2014.10.002","article-title":"Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease","volume":"46","author":"S Lens","year":"2014","journal-title":"Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"key":"ref5","article-title":"From current status to optimization of HCV treatment: Recommendations from an expert panel","author":"A Craxi","year":"2016","journal-title":"Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/JCM.03030-14","article-title":"An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay","volume":"53","author":"C Sarrazin","year":"2015","journal-title":"Journal of clinical microbiology"},{"key":"ref7","article-title":"Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens","author":"B Maasoumy","year":"2016","journal-title":"J Hepatol"},{"key":"ref8","first-page":"55","article-title":"Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties","volume":"242","author":"KE Reed","year":"2000","journal-title":"Current topics in microbiology and immunology"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1053\/jhep.2002.34130","article-title":"Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication","volume":"36","author":"M Bouvier-Alias","year":"2002","journal-title":"Hepatology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jcv.2011.05.003","article-title":"Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay","volume":"51","author":"MC Medici","year":"2011","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcv.2014.05.014","article-title":"Clinical utility of hepatitis C virus core antigen quantification in patients with chronic hepatitis C","volume":"61","author":"S Chevaliez","year":"2014","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jcv.2012.11.012","article-title":"Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C","volume":"56","author":"E Loggi","year":"2013","journal-title":"Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/apt.13261","article-title":"The accuracy and cost-effectiveness of hepatitis C core antigen assay in the monitoring of anti-viral therapy in patients with chronic hepatitis C genotype 4","volume":"42","author":"SM Kamal","year":"2015","journal-title":"Alimentary pharmacology & therapeutics"},{"key":"ref14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.03.035","article-title":"Quantification of Core Antigen Monitors Efficacy of Direct-acting Antiviral Agents in Patients With Chronic Hepatitis C Virus Infection","author":"A Aghemo","year":"2016","journal-title":"Clinical gastroenterology and hepatology: the official clinical practice journal of the American Gastroenterological Association"},{"key":"ref15","article-title":"Clinical utility of HCV core antigen detection and quantification in the diagnosis and management of patients with chronic hepatitis C receiving an all-oral, interferon-free regimen","author":"S Chevaliez","year":"2016","journal-title":"Antiviral therapy"},{"key":"ref16","article-title":"Electronic address eee. EASL Recommendations on Treatment of Hepatitis C 2016","year":"2016","journal-title":"J Hepatol"},{"key":"ref17","unstructured":"America TAAftSoLDatIDSo. Recommendations for Testing, Managing, and Treating Hepatitis C. Last Updated: April 12, 2017. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcvguidelinesorg\" xlink:type=\"simple\">www.hcvguidelinesorg<\/ext-link>. 2017."},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12072-016-9736-3","article-title":"APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing","volume":"10","author":"M Omata","year":"2016","journal-title":"Hepatology international"},{"key":"ref19","article-title":"Guidelines on hepatitis B and C testing","year":"2017"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jviromet.2008.12.009","article-title":"A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen","volume":"157","author":"K Morota","year":"2009","journal-title":"Journal of virological methods"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jviromet.2017.03.002","article-title":"HCV core antigen as an alternate test to HCV RNA for assessment of virologic responses to all-oral, interferon-free treatment in HCV genotype 1 infected patients","volume":"245","author":"JK Rockstroh","year":"2017","journal-title":"Journal of virological methods"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jviromet.2014.11.027","article-title":"Importance of very early HCV RNA kinetics for prediction of treatment outcome of highly effective all oral direct acting antiviral combination therapy","volume":"214","author":"C Sarrazin","year":"2015","journal-title":"Journal of virological methods"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/cid\/ciu782","article-title":"Hepatitis C core antigen testing: a reliable, quick, and potentially cost-effective alternative to hepatitis C polymerase chain reaction in diagnosing acute hepatitis C virus infection","volume":"60","author":"FV Cresswell","year":"2015","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0187755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:44:54Z","timestamp":1540244694000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0187755"}},"subtitle":[],"editor":[{"given":"Ming-Lung","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,11,10]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0187755","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,10]]}}}